The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Artificial intelligence for diabetic retinopathy screening: a review
Open accessAbstract
Diabetes is a global eye health issue. Given the rising in diabetes prevalence and ageing population, this poses significant challenge to perform diabetic retinopathy (DR) screening for these patients. Artificial intelligence (AI) using machine learning and deep learning have been adopted by various groups to develop automated DR detection algorithms. This article aims to describe the state-of-art AI DR screening technologies that have been described in the literature, some of which are already commercially available. All these technologies were designed using different training datasets and technical methodologies. Although many groups have published robust diagnostic performance of the AI algorithms for DR screening, future research is required to address several challenges, for examples medicolegal implications, ethics, and clinical deployment model in order to expedite the translation of these novel technologies into the healthcare setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Artificial intelligence (AI) for medical diagnosis holds potential, demonstrating high performance in detecting various diseases.57”
From Using artificial intelligence to improve human performance: efficient retinal disease detection training with synthetic images (2024) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362
Gulshan, V., Peng, L., Coram, M., Stumpe, M. C., Wu, D., Narayanaswamy, A., Venugopalan, S., Widner, K., Madams, T., Cuadros, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.17216 · Cited by 7,697
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning
Kermany, D. S., Goldbaum, M., Cai, W., Valentim, C. C. S., Liang, H., Baxter, S. L., McKeown, A., Yang, G., Wu, X., Yan, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.010 · Cited by 4,842
Clinically applicable deep learning for diagnosis and referral in retinal disease
De Fauw, J., Ledsam, J. R., Romera-Paredes, B., Nikolov, S., Tomasev, N., Blackwell, S., Askham, H., Glorot, X., O’Donoghue, B., Visentin, D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0107-6 · Cited by 2,639
Ting, D. S. W., Cheung, C. Y.-L., Lim, G., Tan, G. S. W., Quang, N. D., Gan, A., Hamzah, H., Garcia-Franco, R., San Yeo, I. Y., Lee, S. Y., et al. (2017) · JAMA · doi:10.1001/jama.2017.18152 · Cited by 2,402
Lakhani, P., & Sundaram, B. (2017) · Radiology · doi:10.1148/radiol.2017162326 · Cited by 1,775
Abràmoff, M. D., Lavin, P. T., Birch, M., Shah, N., & Folk, J. C. (2018) · npj Digital Medicine · doi:10.1038/s41746-018-0040-6 · Cited by 1,638
Automated Identification of Diabetic Retinopathy Using Deep Learning
Gargeya, R., & Leng, T. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.02.008 · Cited by 1,410
Cited by
Sorted by citations
Manickam, P., Mariappan, S. A., Murugesan, S. M., Hansda, S., Kaushik, A. K., Shinde, R. B., & Thipperudraswamy, S. P. (2022) · Biosensors · doi:10.3390/bios12080562 · Cited by 717
Bekbolatova, M., Mayer, J., Ong, C. W., & Toma, M. (2024) · Healthcare · doi:10.3390/healthcare12020125 · Cited by 450
“In the past, identifying DR relied solely on human clinicians or graders [67].”
BackgroundArtificial Intelligence: The Future for Diabetes Care
Ellahham, S. H. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.03.033 · Cited by 404
Freeman, K., Geppert, J., Stinton, C., Todkill, D., Johnson, S. A., Clarke, A., & Taylor‐Phillips, S. (2021) · BMJ · doi:10.1136/bmj.n1872 · Cited by 365
“47 48 Beyond conventional screening programmes, the use of deep learning in medicine is increasing, and has been considered in the diagnosis of melanoma, 49 ophthalmic diseases (age-related macular degeneration 50 and glaucoma 51 ), and in interpretation of histological, 52 radiological, 53 and…”
BackgroundDeep learning for diabetic retinopathy detection and classification based on fundus images: A review
Tsiknakis, N., Theodoropoulos, D., Manikis, G. C., Ktistakis, E., Boutsora, O., Bertó, A., Scarpa, F., Scarpa, A., Fotiadis, D. I., & Kostas Marias, A. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104599 · Cited by 359
“Although some review articles regarding the application of deep learning methods on DR have been published during the past few years [18 – 22], most of them focus only on specific aspects of the data analysis and modeling pipeline, as is presented in Fig.”
BackgroundDeep Learning for Diabetes: A Systematic Review
Zhu, T., Li, K., Herrero, P., & Georgiou, P. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.3040225 · Cited by 290
“As an emerging approach, deep learning has recently shown competitive performance in several important fields of diabetes, such as diabetic eye diseases [27].”
BackgroundArtificial intelligence technologies and compassion in healthcare: A systematic scoping review
Morrow, E. M., Zidaru, T., Ross, F., Mason, C. L., Patel, K. D., Ream, M., & Stockley, R. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.971044 · Cited by 308
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
Amoaku, W. M. K., Ghanchi, F. D., Bailey, C., Banerjee, S., Banerjee, S., Downey, L., Gale, R. P., HAMILTON, R. D., Khunti, K., Posner, E., et al. (2020) · Eye · doi:10.1038/s41433-020-0961-6 · Cited by 231
Artificial Intelligence Applications in Health Care Practice: Scoping Review
Sharma, M., Savage, C., Nair, M., Larsson, I., Svedberg, P., & Nygren, J. M. (2022) · Journal of Medical Internet Research · doi:10.2196/40238 · Cited by 198
Rajesh, A. E., Davidson, O. Q., Lee, C. S., & Lee, A. (2023) · Diabetes Care · doi:10.2337/dci23-0032 · Cited by 175
Jha, N., Shankar, P. R., Al-Betar, M. A., Mukhia, R., Hada, K., & Palaian, S. (2022) · Advances in Medical Education and Practice · doi:10.2147/amep.s368519 · Cited by 143
“20 Of the student respondents, nearly half felt AI can analyze patient information to reach diagnoses while it is clearly documented in the literature that AI can perform as well as or better than human beings in diagnosing diseases.”
BackgroundGomez Rossi, J., Rojas-Perilla, N., Krois, J., & Schwendicke, F. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0269 · Cited by 141
Saheb, T., Saheb, T., & Carpenter, D. O. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104660 · Cited by 148
Zidaru, T., Morrow, E. M., & Stockley, R. (2021) · Health Expectations · doi:10.1111/hex.13299 · Cited by 143
Automated identification of retinopathy of prematurity by image-based deep learning
Tong, Y., Lü, W., Deng, Q., Chen, C., & Shen, Y. (2020) · Eye and Vision · doi:10.1186/s40662-020-00206-2 · Cited by 114
“DL has achieved automated detection of retinal diseases [12, 13], including diabetic retinopathy [14], glaucoma [15], age-related macular degeneration, and cataracts [16].”
BackgroundTransfer Learning-Based Model for Diabetic Retinopathy Diagnosis Using Retinal Images
Jabbar, M. K., Yan, J., Xu, H., Rehman, Z. U., & Jabbar, A. (2022) · Brain Sciences · doi:10.3390/brainsci12050535 · Cited by 105
“There are more than 158.2 million people currently suffering from DR, and this number is estimated to increase to about 191 million by 2030 [5].”
BackgroundInfluentialRetina Fundus Photograph-Based Artificial Intelligence Algorithms in Medicine: A Systematic Review
Grzybowski, A. E., Jin, K., Zhou, J., Pan, X., Wang, M., Ye, J., & Wong, T. Y. (2024) · Ophthalmology and Therapy · doi:10.1007/s40123-024-00981-4 · Cited by 116
“Various AI-based screening tools have been developed, such as Retmarker DR, Eye Art, and the Bosch DR algo-rithm, which use convolutional neural networks to analyze retinal images for DR detection and progression tracking [13].”
MethodMackenzie, S. C., Sainsbury, C. A. R., & Wake, D. J. (2023) · Diabetologia · doi:10.1007/s00125-023-06038-8 · Cited by 97
“Many autonomous AI systems for diabetic retinopathy detection have been or are now being developed and, in some cases, are built into commercially available systems displaying safety and efficacy, resulting in Food and Drug Administration (FDA) approval [30–32].”
BackgroundSelvachandran, G., Quek, S. G., Paramesran, R., Ding, W., & Sơn, L. H. (2022) · Artificial Intelligence Review · doi:10.1007/s10462-022-10185-6 · Cited by 99
“…gone through many review articles published previously (Amin et al. 2016; Lu et al. 2018; Ting et al. 2018; Sorour et al. 2018; Raman et al. 2019; Grzybowski et al. 2019; Nagendran et al. 2020; Yip et al. 2020; Chaki et al. 2020; Alyoubi et al. 2020; Stolte and Fang 2020; Kandel and Castelli…”
BackgroundFFU‐Net: Feature Fusion U‐Net for Lesion Segmentation of Diabetic Retinopathy
Xu, Y., Zhou, Z., Li, X., Zhang, N., Zhang, M., & Wei, P. (2021) · BioMed Research International · doi:10.1155/2021/6644071 · Cited by 86
“With the rapid development of deep learning technology, many researchers resort to deep learning methods to segment the lesion of diabetic retinopathy [3].”
BackgroundIntroduction to Artificial Intelligence and Machine Learning for Pathology
Harrison, J. H., Gilbertson, J. R., Hanna, M. G., Olson, N. H., Seheult, J. N., Sorace, J. M., & Stram, M. N. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0541-cp · Cited by 91
“One of the first machine learning applications to be approved for clinical use interprets funduscopic images automatically for assessment of diabetic retinopathy.(17,18) Other health care imaging applications in development include classification of gross dermatology images,(19) radiology images,(20) and pathology ima…”
BackgroundThe Role of Artificial Intelligence in Surgery
Hashimoto, D. A., Ward, T. M., & Meireles, O. R. (2020) · Advances in Surgery · doi:10.1016/j.yasu.2020.05.010 · Cited by 85
The State of Radiology AI: Considerations for Purchase Decisions and Current Market Offerings
Tadavarthi, Y., Vey, B. L., Krupinski, E. A., Prater, A. B., Gichoya, J. W., Safdar, N. M., & Trivedi, H. (2020) · Radiology Artificial Intelligence · doi:10.1148/ryai.2020200004 · Cited by 78
“AI has also been leveraged extensively for imaging tasks such as identification of intracranial hemorrhage at head CT (6) and identifying diabetic retinopathy at fundoscopic examinations (7,8).”
BackgroundRomero-Oraá, R., Herrero-Tudela, M., López, M. I., Hornero, R., & García, M. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108160 · Cited by 91
Mayya, V., Kamath, S. S., & Kulkarni, U. (2021) · Computer Methods and Programs in Biomedicine Update · doi:10.1016/j.cmpbup.2021.100013 · Cited by 76
Artificial intelligence to enhance clinical value across the spectrum of cardiovascular healthcare
Gill, S. K., Karwath, A., Uh, H., Cardoso, V. R., Gu, Z., Barsky, A., Slater, L. T., Acharjee, A., Duan, J., Dall’Olio, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac758 · Cited by 81
“25,34 As with any emerging technique, the actual impact of AI is still being demonstrated, and this also applies to the case studies described.”
MethodPreston, F. G., Meng, Y., Burgess, J., Ferdousi, M., Azmi, S., Petropoulos, I. N., Kaye, S., Malik, R. A., Zheng, Y., & Alam, U. (2022) · Diabetologia · doi:10.1007/s00125-021-05617-x · Cited by 70
“However, the development of such AIbased systems requires the acquisition of large image/datasets with human-graded (ground truth) annotations as a reference standard to train the algorithm [44].”
BackgroundCurrent Status and Emerging Options for Automated Insulin Delivery Systems
Forlenza, G. P., & Lal, R. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0514 · Cited by 70
Grzybowski, A., & Brona, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112352 · Cited by 64
“A number of artificial intelligence solutions for use in DR screening programs, some authorized for autonomous use, are currently available with more in the pipeline [6].”
BackgroundIlan, Y. (2020) · Frontiers in Digital Health · doi:10.3389/fdgth.2020.569178 · Cited by 68
“Prospective studies have shown limited benefit in diabetic retinopathy grading (82–84), detection of breast cancer metastases in lymph node biopsies (85), wrist fracture detection (86), colonic polyp detection (87), and detection of atrial fibrillation in Apple watch users (10, 88).”
BackgroundArtificial intelligence in diabetic retinopathy: Bibliometric analysis
Poly, T. N., Islam, M. M., Walther, B. A., Lin, M. C., & Li, Y. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107358 · Cited by 61
Artificial intelligence and machine learning in ophthalmology: A review
Srivastava, O., TENNANT, M. T. S., Grewal, P. S., Rubin, U., & Seamone, M. E. (2022) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1569_22 · Cited by 63
“[20,21] Age-related macular degeneration Age‑related macular degeneration (AMD) is a common cause of vision loss, with an estimated 196 million patients impacted globally.”
Detecting visually significant cataract using retinal photograph-based deep learning
Tham, Y. C., Goh, J. H. L., Anees, A., Lei, X., Rim, T. H., Chee, M.-L., Wang, Y. X., Jonas, J. B., Thakur, S., Teo, Z. L., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00171-6 · Cited by 59
“A secondary potential application would be on DR-screening programs in which cataracts are a common cause of ungrad-able retinal photographs 21–24 .”
BackgroundHuemer, J. C., Wagner, S. K., & Sim, D. A. (2020) · Clinical ophthalmology · doi:10.2147/opth.s261629 · Cited by 63
Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review
Ahmed, A., Aziz, S., Abd-alrazaq, A., Farooq, F., & Sheikh, J. (2022) · Journal of Medical Internet Research · doi:10.2196/36010 · Cited by 57
Ophthalmic imaging in diabetic retinopathy: A review
Nanegrungsunk, O., Patikulsila, D., & Sadda, S. R. (2022) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14170 · Cited by 53
“, IA, USA]).(99) Many more such tools are Conformitè Europëenne (CE) marked in the European Union.”
BackgroundIt is time for a moonshot to find “Cures” for diabetic retinal disease
Levine, S. R., Sapieha, P. S., Dutta, S., Sun, J. K., & Gardner, T. W. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101051 · Cited by 53
“…& Abramoff, 2021a, 2021b), greater access to well characterized cohorts of people with diabetes (Levi et al., S.R. Levine et al. 2021; Chua et al., 2019; Hietala et al., 2008; Sobrin et al., 2021; J. K. Sun et al., 2011), and potential utility of artificial intelligence (Grzybowski et al., 2020).”
Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers
Parravano, M., Cennamo, G., Antonio, L. D., Grassi, M. O., Lupidi, M., Rispoli, M., Savastano, M. C., Veritti, D., & Vujosevic, S. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.06.006 · Cited by 51
Teleophthalmology: an essential tool in the era of the novel coronavirus 2019
Kalavar, M., Hua, H.-U., & Sridhar, J. S. (2020) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000689 · Cited by 48
“Diabetic retinopathy was one of the first validated applications of teleophthalmology, and integration with artificial intelligence has made this method of screening even more accurate and cost-effective [53,57].”
BackgroundOng, J. X., Konopek, N., Fukuyama, H., & Fawzi, A. A. (2022) · Ophthalmology Retina · doi:10.1016/j.oret.2022.06.018 · Cited by 50
A Systematic Literature Review on Diabetic Retinopathy Using an Artificial Intelligence Approach
Bidwai, P., Gite, S., Pahuja, K., & Kotecha, K. V. (2022) · Big Data and Cognitive Computing · doi:10.3390/bdcc6040152 · Cited by 50
“Convolutional neural networks (CNN), deep Boltzmann machines (DBM), autoencoders, deep neural networks (DNN), recurrent neural networks (RNN), deep belief networks (DBN), and generative adversarial networks (GAN) are only a few of the DL-based techniques [80].”
BackgroundLi, S., Ren, M., Gan, J., Zhang, S.-G., Kang, M., Li, H., Atchison, D. A., Rozema, J., Grzybowski, A. E., Wang, N., et al. (2022) · Ophthalmology and Therapy · doi:10.1007/s40123-021-00450-2 · Cited by 49
“In the field of ophthalmology, machine learning has been used in diagnosis of diabetic retinopathy [18], predictions of myopia development [19, 20], orthokeratology lens prescription [21, 22], and visual acuity in patients treated for neovascular age-related macular degeneration [23].”
BackgroundEDR-Net: Lightweight Deep Neural Network Architecture for Detecting Referable Diabetic Retinopathy
Aujih, A. B., Shapiai, M. I., Mériaudeau, F., & Tang, T. B. (2022) · IEEE Transactions on Biomedical Circuits and Systems · doi:10.1109/tbcas.2022.3182907 · Cited by 49
Bach, A. K. P., Nørgaard, T. M., Brok, J. C., & van Berkel, N. (2023) · Proceedings of the 2023 CHI Conference on Human Factors in Computing Systems · doi:10.1145/3544548.3581513 · Cited by 47
“state that even if AI assessment systems increase in quality, clinical experts will still be required to assess atypical situations and low-quality images, as well as for quality monitoring [21].”
BackgroundPredicting Keratoconus Progression and Need for Corneal Crosslinking Using Deep Learning
Kato, N., Masumoto, H., Tanabe, M., Sakai, C., Negishi, K., Torii, H., Tabuchi, H., & Tsubota, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040844 · Cited by 46
Li, L., Zhou, E., Yu, W., Chen, B., Ren, P., Lu, Q., Qin, D., Lu, L., He, Q., Tang, X., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02758-y · Cited by 45
The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases
Desideri, L. F., Rutigliani, C., Corazza, P., Nastasi, A., Roda, M., Nicolò, M., Traverso, C. E., & Vagge, A. (2022) · Journal of Optometry · doi:10.1016/j.optom.2022.08.001 · Cited by 50
“19 More recently, there has been a signi fi cant advancement in smartphone-based AI.”
BackgroundYip, M. Y. T., Lim, G., Lim, Z. W., Nguyen, Q. D., Chong, C. C. Y., Yu, M., Bellemo, V., Xie, Y., Lee, X. Q., Hamzah, H., et al. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0247-1 · Cited by 43
Srisubat, A., Kittrongsiri, K., Sangroongruangsri, S., Khemvaranan, C., Shreibati, J. B., Ching, J., Hernandez, J., Tiwari, R., Hersch, F. B., Liu, Y., et al. (2023) · Ophthalmology and Therapy · doi:10.1007/s40123-023-00688-y · Cited by 42
Yang, Q., Bee, Y. M., Lim, C. C., Sabanayagam, C., Yim-Lui Cheung, C., Wong, T. Y., Ting, D. S. W., Lim, L.-L., Li, H., He, M., et al. (2025) · eClinicalMedicine · doi:10.1016/j.eclinm.2025.103089 · Cited by 38
“…and policy development. multiple studies have develop and validated the use of AI algorithms on retina imaging for various applications including the diagnosis and management of conditions such as diabetic retinopathy, 8 glaucoma, 9 age-related macular degeneration, 9 and other retinal diseases.”
Self-citationArtificial intelligence in ophthalmology
Patoni, S. I. P., Muşat, A. A. M., Patoni, C., Popescu, M.-N., Munteanu, M., Costache, I. B., Pîrvulescu, R. A., & Mușat, O. (2023) · Romanian Journal of Ophthalmology · doi:10.22336/rjo.2023.37 · Cited by 38
“IDP specificity was 70%, and IDP sensitivity was 86.7% [ 60,62-64 ].”
BackgroundMethodInfluentialBoffetta, P., & Collatuzzo, G. (2022) · La Medicina del Lavoro · doi:10.23749/mdl.v113i1.12622 · Cited by 50
Machine Learning and Deep Learning Techniques for Optic Disc and Cup Segmentation – A Review
Alawad, M., Aljouie, A., Alamri, S., Alghamdi, M., Alabdulkader, B., Alkanhal, N., & Almazroa, A. A. (2022) · Clinical ophthalmology · doi:10.2147/opth.s348479 · Cited by 41
“The SiDRP started to integrate AI algorithms into their workflow with the ultimate goal of fully automating the screening process, increasing efficiency, and reducing the cost for the whole program.(118) One proven application for AI within healthcare is clinical decision support.”
Artificial Intelligence Meets Neuro-Ophthalmology
Leong, Y.-Y., Vasseneix, C., Finkelstein, M. T., Miléa, D., & Najjar, R. P. (2022) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000512 · Cited by 39
“In ophthalmology, AI algorithms have been developed for the detection of diabetic retinopathy, 9,10 glaucoma, 11–13 age-related macular degeneration, 14–16 and retinopathy of prematurity.”
BackgroundDiabetic retinopathy detection using supervised and unsupervised deep learning: a review study
Naz, H. U., Ahuja, N. J., & Nijhawan, R. (2024) · Artificial Intelligence Review · doi:10.1007/s10462-024-10770-x · Cited by 39
Novel Approaches for Early Detection of Retinal Diseases Using Artificial Intelligence
Sorrentino, F. S., Gardini, L., Fontana, L., Musa, M., Gabai, A., Maniaci, A., Lavalle, S., D’Esposito, F., Russo, A., Longo, A., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070690 · Cited by 42
“Ultimately, while AI devices hold great promise in alleviating the global burden of DR screening, addressing additional knowledge gaps is imperative to harness the full potential of this emerging technology [19].”
BackgroundUrsin, F., Timmermann, C., Orzechowski, M., & Steger, F. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.695217 · Cited by 32
Global trends and performances in diabetic retinopathy studies: A bibliometric analysis
Xiao, H., Tang, J., Zhang, F., Liu, L., Zhou, J. J., Chen, M., Li, M., Wu, X., Nie, Y., & Duan, J. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1128008 · Cited by 36
“However, an ethical review of a large number of original data is required for the research of AI algorithms, and the application of clinical care must be properly standardized and deployed (67, 68).”
BackgroundGrzybowski, A., Rao, D. P., Brona, P., Negiloni, K., Krzywicki, T., & Savoy, F. M. (2023) · Ophthalmic Research · doi:10.1159/000534098 · Cited by 33
“There are only a few established nationwide DR screening programs, and overall DR screening services remain inadequate in most of the developing world and even some developed countries [1].”
BackgroundSelf-citationMunishKhanna, Singh, L. K., & Garg, H. (2023) · Multimedia Tools and Applications · doi:10.1007/s11042-023-16236-6 · Cited by 33
“One alternative remedy for the aforementioned problems is automated DR screening, which is very effective, inexpensive, and requires fewer medical professionals [26].”
RetractedRadiomics-Based Assessment of OCT Angiography Images for Diabetic Retinopathy Diagnosis
Carrera-Escalé, L., Benali, A., Rathert, A.-C., Martín, R., Bernal-Morales, C., Alé-Chilet, A., Barraso, M., Marín-Martínez, S., Feu-Basilio, S., Rosinés-Fonoll, J., et al. (2022) · Ophthalmology Science · doi:10.1016/j.xops.2022.100259 · Cited by 32
Aging under endocrine hormone regulation
Xing, Y., Fan, X., Wang, K., & Zhang, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1223529 · Cited by 33
Bala, R., Sharma, A., & Goel, N. (2023) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-023-10002-5 · Cited by 31
“Some are directed to provide only DR screening aspect and do not discuss the multi-classification aspect [23, 24].”
Gonçalves, M. B., Nakayama, L., Ferraz, D., Faber, H., Korot, E., Malerbi, F., Regatieri, C., Maia, M., Celi, L., Keane, P., et al. (2023) · Eye · doi:10.1038/s41433-023-02717-3 · Cited by 32
“Recently, artificial intelligence (AI) and deep learning (DL) algorithms have been reported to achieve robust performance in detecting DR from retinal photographs, representing a promising tool to manage the large amount of image data generated by screening programs [2, 6–9].”
The application of artificial intelligence in diabetic retinopathy: progress and prospects
Xu, X., Zhang, M., Huang, S., Li, X., Kui, X., & Liu, J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1473176 · Cited by 31
Wanichwecharungruang, B., Kaothanthong, N., Pattanapongpaiboon, W., Chantangphol, P., Seresirikachorn, K., Srisuwanporn, C., Parivisutt, N., Grzybowski, A. E., Theeramunkong, T., & Ruamviboonsuk, P. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.1.7 · Cited by 31
Zhang, Q., Sampani, K., Xu, M., Cai, S., Deng, Y., Li, H., Sun, J. K., & Karniadakis, G. E. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.8.7 · Cited by 31
“With the recent advances in the computational power of graphics processing units (GPUs), deep convolutional neural networks (DCNNs) have become a widely used tool for efficient DR screening [29].”
BackgroundDoğan, M. E., Bilgin, A., Sarı, R., Bulut, M., Akar, Y., & Aydemir, M. (2024) · Eye · doi:10.1038/s41433-024-03000-9 · Cited by 24
“[7]).”
Impact and Trends in Global Ophthalmology
Williams, L. B., Prakalapakorn, S. G., Ansari, Z., & Goldhardt, R. (2020) · Current Ophthalmology Reports · doi:10.1007/s40135-020-00245-x · Cited by 31
“, Coimbra, Portugal), Singapore SERI-NUS (Singapore Eye Research Institute – National University of Singapore, Singapore), the Bosch DR algorithm (Robert Bosch GmbH, Bangalore, India), RetinaLyze® (RetinaLyze system A/S, Hellerup, Denmark)) [25].”
MethodSaiviroonporn, P., Rodbangyang, K., Tongdee, T., Chaisangmongkon, W., Yodprom, P., Siriapisith, T., Wonglaksanapimon, S., & Thiravit, P. (2021) · BMC Medical Imaging · doi:10.1186/s12880-021-00625-0 · Cited by 29
Porporato, N., Tun, T. A., Baskaran, M., Wong, D. W. K., Husain, R., Fu, H., Sultana, R., Perera, S., Schmetterer, L. F., & Aung, T. (2021) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-318275 · Cited by 29
Chaitanuwong, P., Singhanetr, P., Chainakul, M., Arjkongharn, N., Ruamviboonsuk, P., & Grzybowski, A. E. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00526-0 · Cited by 28
“AI algorithms can extract both known and unknown features from images and provide a reliable diagnosis without the need for manual feature identification, as has been shown for eye diseases where AI has been used on retinal images to identify such eye diseases as age-related macular degeneration [7], glaucoma [8], pap…”
BackgroundMaloca, P. M., Müller, P. L., Lee, A., Tufail, A., Balaskas, K., Niklaus, S., Kaiser, P., Suter, S. K., Zarranz‐Ventura, J., Egan, C. A., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01697-y · Cited by 28
Ryu, G., Lee, K., Park, D.-G., Kim, I., Park, S. H., & Sagong, M. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.2.39 · Cited by 30
Diabetic Retinopathy Classification Using Swin Transformer with Multi Wavelet
Dihin, R. A., AlShemmary, E. N., & Al‐Jawher, W. A. M. (2023) · Journal of Kufa for Mathematics and Computer · doi:10.31642/jokmc/2018/100225 · Cited by 28
“These statistics have become a global epidemic [2].”
BackgroundKubin, A., Huhtinen, P., Ohtonen, P. P., Keskitalo, A., Wirkkala, J., & Hautala, N. M. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2352018 · Cited by 28
“…the knowledge and understanding of the possibilities and limitations of ai solutions is crucial for their successful use in a real-world setting: patient acceptability, data privacy, data protection, regulations, including medico-legal aspects, are among the issues that need to be considered [23].”
BackgroundMachine Learning and Deep Learning Techniques for Optic Disc and Cup Segmentation – A Review
Alawad, M., Aljouie, A., Alamri, S., Alghamdi, M., Alabdulkader, B., Alkanhal, N., & Almazroa, A. A. (2022) · Dove Medical Press (Taylor and Francis Group) · Cited by 27
Noriega-Campero, A., Meizner, D., Camacho‐García‐Formentí, D., Enciso, J., Quiroz-Mercado, H., Morales-Cantón, V., Almaatouq, A., & Pentland, A. (2021) · JMIR Formative Research · doi:10.2196/25290 · Cited by 23
Therapeutic Screening of Herbal Remedies for the Management of Diabetes
Balbaa, M., El‐Zeftawy, M., & Abdulmalek, S. A. (2021) · Molecules · doi:10.3390/molecules26226836 · Cited by 28
Faura, G., Boix‐Lemonche, G., Holmeide, A. K., Verkauskienė, R., Volke, V., Sokolovska, J., & Petrovski, G. (2022) · Sensors · doi:10.3390/s22030718 · Cited by 26
“ML models have proved to be robust for the diagnosis of several diseases [39–43], including ophthalmology-related ones [4,14].”
BackgroundRuan, S., Hu, W., Jia, H., Wang, S., Song, M.-L., Shen, M.-X., Luo, D., Ye, T., & Wang, F. (2022) · International Journal of Ophthalmology · doi:10.18240/ijo.2022.04.16 · Cited by 27
Research Progress and Prospects of Intelligent Diabetes Monitoring Systems: A Review
Zou, Y., Chu, Z., Yang, T., Guo, J., & Li, D. (2024) · IEEE Sensors Journal · doi:10.1109/jsen.2024.3411570 · Cited by 27
“Grzybowski et al. [228] provide a detailed overview of the use of AI in diabetic retinopathy screening and discuss some of the challenges that need to be addressed for future research.”
BackgroundRetinal vascular tortuosity: Mechanisms and measurements
Vilela, M. A. P., Amaral, C. E. V., & Ferreira, M. A. T. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672120979907 · Cited by 25
Kiel, M., Grabitz, S. D., Hopf, S., Koeck, T., Wild, P. S., Schmidtmann, I. M., Lackner, K. J., Münzel, T. F., Beutel, M. E., Pfeiffer, N., et al. (2022) · Journal of Ophthalmology · doi:10.1155/2022/9520512 · Cited by 25
“New approaches using AI algorithms evaluate these fundus images with regard to the presence and stage of diabetic retinopathy [3, 4].”
MethodMehra, A. A., Softing, A., Guner, M. K., Hodge, D. O., & Barkmeier, A. J. (2022) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.08.008 · Cited by 24
Rao, D. P., Savoy, F. M., Tan, J. Z. E., Fung, B., Bopitiya, C. M., Sivaraman, A., & Vinekar, A. S. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1197237 · Cited by 28
Hybrid CNN-LSTM for Predicting Diabetes: A Review
Soltanizadeh, S., & Naghibi, S. S. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998261151230925062430 · Cited by 25
Duggal, M., Chauhan, A., Gupta, V., Kankaria, A., Budhija, D., Verma, P., Miglani, V., Syal, P., Kaur, G., Kumar, L., et al. (2025) · JMIR Medical Informatics · doi:10.2196/67529 · Cited by 24
“Conventional screening with trained human graders is often costly, time-consuming, and challenging to scale [5,6].”
Boucher, M. C., Qian, J., Brent, M. H., Wong, D. T., Sheidow, T., Duval, R., Kherani, A., Dookeran, R. I., Maberley, D., Samad, A., et al. (2020) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2020.01.001 · Cited by 24
Artificial Intelligence to Detect Meibomian Gland Dysfunction From in-vivo Laser Confocal Microscopy
Zhang, Y., Zhao, H., Lin, J., Wu, S., Liu, X., Zhang, H.-D., Shao, Y., & Yang, W. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.774344 · Cited by 24
Artificial intelligence in uveitis: A comprehensive review
Nakayama, L. F., Ribeiro, L. Z., Dychiao, R. G., Zamora, Y. F., Regatieri, C. V., Celi, L. A., Silva, P., Sobrin, L., & Belfort, R. (2023) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2023.02.007 · Cited by 24
Diabetic retinopathy disease detection using shapley additive ensembled densenet-121 resnet-50 model
Mary, A. R., & Kavitha, P. (2024) · Multimedia Tools and Applications · doi:10.1007/s11042-024-18309-6 · Cited by 23
“Diabetic retinopathy is a common vision loss among employed people in urbanized countries caused by the problem of diabetic mellitus [1].”
Evaluation and Regulation of Artificial Intelligence Medical Devices for Clinical Decision Support
Weissman, G. E. (2025) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-103123-095824 · Cited by 31
Recent Advances and Clinical Application of Color Scanning Laser Ophthalmoscope
Terasaki, H., Sonoda, S., Tomita, M., & Sakamoto, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040718 · Cited by 23
Dong, X., Du, S., Zheng, W., Cai, C., Liu, H., & Zou, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.883462 · Cited by 24
“IDx-DR (Digital Diagnostics, Coralville, USA), Selena (EyRIS, Singapore), Google Inception, and Robert Bosch GmbH (Gerlingen-Schillerhöhe, Germany) are the most widely used systems (12).”
Review on diabetic retinopathy with deep learning methods
Shekar, S. C., Satpute, N., & Gupta, A. (2021) · Journal of Medical Imaging · doi:10.1117/1.jmi.8.6.060901 · Cited by 19
“120, the commercially available latest DR screening technologies are summarized, which include IDx-DR, RetmarkerDR, EyeArt, Google, Singapore SERI-NUS, Bosch DR algo-rithm, and Retinalyze.”
MethodEyeArt artificial intelligence analysis of diabetic retinopathy in retinal screening events
Vought, R., Vought, V., Shah, M., Szirth, B., & Bhagat, N. (2023) · International Ophthalmology · doi:10.1007/s10792-023-02887-9 · Cited by 23
“DR screening programs, typically involving fundus photography and review by a specially—telemedicine grader, have become prevalent to address increasing rates of DR and maintain adequate community surveillance [8].”
Gao, W., Fan, B., Fang, Y., & Song, N. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107854 · Cited by 23
Tabuchi, H., Engelmann, J., Maeda, F., Nishikawa, R., Nagasawa, T., Yamauchi, T., Tanabe, M., Akada, M., Kihara, K., Nakae, Y., et al. (2024) · British Journal of Ophthalmology · doi:10.1136/bjo-2023-324923 · Cited by 22
“4 7 However, challenges such as decreased performance on unseen imaging modalities and the commercially available AI diagnosis, which is difficult for medical insurance systems to cover, 8 need to be addressed to fully harness AI’s potential and ensure its accessibility and effectiveness for…”
BackgroundArtificial Intelligence in Uveitis: Innovations in Diagnosis and Therapeutic Strategies
Murugan, S., Sanjay, S., Somanath, A., Mahendradas, P., Patil, A., Kaur, K., & Gurnani, B. (2024) · Clinical ophthalmology · doi:10.2147/opth.s495307 · Cited by 24
“20 Abellanas et al 21 in their review of AI in uveitis noted that presently the performance of AI models were poor with limited datasets and a lack of validation studies and publicly available data and codes.”
Metadata
- Authors
- Grzybowski, A., Brona, P., Lim, G., Ruamviboonsuk, P., Tan, G. S. W., Abramoff, M., & Ting, D. S. W.
- Affiliations
- Foundation for the Development of Ophthalmology (PL)
- University of Warmia and Mazury in Olsztyn (PL)
- National University of Singapore (SG)
- Rajavithi Hospital (TH)
- Corresponding author
- Ting, Daniel S. W.
- ORCID
- Venue
- Eye
- Published
- 2019-09-05
- Volume
- 34
- Issue
- 3
- Pages
- 451-460
- ISSN
- 0078-5334 (ISSN-L)
- 0950-222X
- 1476-5454
- PMC
- PMC7055592
- OpenAlex
- W2972246881
- Cited by
- 376
- References
- 36
- Citations by year
- 2026: 34 · 2025: 69 · 2024: 70 · 2023: 76 · 2022: 63 · 2021: 40 · 2020: 21 · 2019: 2
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-12-10)
- Open access
- bronze
- doi.org
- Locations
- Eye (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
- Keywords
- diabetic retinopathy, retinopathy screening, artificial intelligence, automated detection algorithm, deep learning, machine learning, medicolegal issues, ethics, clinical deployment
- MeSH terms
- Machine Learning, Algorithms, Artificial Intelligence, Diabetes Mellitus, Diabetic Retinopathy, Humans, Mass Screening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review